Pfizer Looks to Sell Stake in Pandemic Vaccine Partner BioNTech

Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations.

By Sonja Wind, Anthony Hughes · Bloomberg Markets

Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations.